Skip to main content
Clinical Trials/NCT06218719
NCT06218719
Not yet recruiting
Not Applicable

Examining Engagement Patterns: An Observational Exploration About Tardive Dyskinesia Clinical Trials

Power Life Sciences Inc.1 site in 1 country500 target enrollmentFebruary 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tardive Dyskinesia
Sponsor
Power Life Sciences Inc.
Enrollment
500
Locations
1
Primary Endpoint
Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials.

These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.

Registry
clinicaltrials.gov
Start Date
February 2025
End Date
February 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of tardive dyskinesia
  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
  • No prior treatment for tardive dyskinesia

Exclusion Criteria

  • Enrolled in another research study
  • Inability to provide written informed consent
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a tardive dyskinesia clinical research.

Time Frame: 3 months

Number of tardive dyskinesia study participants who remain in clinical study until completion.

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials